1az5
From Proteopedia
| Line 1: | Line 1: | ||
| - | [[Image:1az5.gif|left|200px]] | + | [[Image:1az5.gif|left|200px]] |
| - | + | ||
| - | '''UNLIGANDED SIV PROTEASE STRUCTURE IN AN "OPEN" CONFORMATION''' | + | {{Structure |
| + | |PDB= 1az5 |SIZE=350|CAPTION= <scene name='initialview01'>1az5</scene>, resolution 2.0Å | ||
| + | |SITE= <scene name='pdbsite=NUL:Catalytic+ASP'>NUL</scene> | ||
| + | |LIGAND= | ||
| + | |ACTIVITY= [http://en.wikipedia.org/wiki/HIV-1_retropepsin HIV-1 retropepsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.16 3.4.23.16] | ||
| + | |GENE= SIV(MAC)239 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=11723 Simian immunodeficiency virus]) | ||
| + | }} | ||
| + | |||
| + | '''UNLIGANDED SIV PROTEASE STRUCTURE IN AN "OPEN" CONFORMATION''' | ||
| + | |||
==Overview== | ==Overview== | ||
| Line 7: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
| - | 1AZ5 is a [ | + | 1AZ5 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Simian_immunodeficiency_virus Simian immunodeficiency virus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1AZ5 OCA]. |
==Reference== | ==Reference== | ||
| - | Domain flexibility in retroviral proteases: structural implications for drug resistant mutations., Rose RB, Craik CS, Stroud RM, Biochemistry. 1998 Feb 24;37(8):2607-21. PMID:[http:// | + | Domain flexibility in retroviral proteases: structural implications for drug resistant mutations., Rose RB, Craik CS, Stroud RM, Biochemistry. 1998 Feb 24;37(8):2607-21. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/9485411 9485411] |
[[Category: HIV-1 retropepsin]] | [[Category: HIV-1 retropepsin]] | ||
[[Category: Simian immunodeficiency virus]] | [[Category: Simian immunodeficiency virus]] | ||
| Line 17: | Line 26: | ||
[[Category: Rose, R B.]] | [[Category: Rose, R B.]] | ||
[[Category: Stroud, R M.]] | [[Category: Stroud, R M.]] | ||
| - | [[Category: | + | [[Category: aid]] |
[[Category: aspartyl protease]] | [[Category: aspartyl protease]] | ||
[[Category: endonuclease]] | [[Category: endonuclease]] | ||
| Line 23: | Line 32: | ||
[[Category: proteinase]] | [[Category: proteinase]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 10:04:11 2008'' |
Revision as of 08:04, 20 March 2008
| |||||||
| , resolution 2.0Å | |||||||
|---|---|---|---|---|---|---|---|
| Sites: | |||||||
| Gene: | SIV(MAC)239 (Simian immunodeficiency virus) | ||||||
| Activity: | HIV-1 retropepsin, with EC number 3.4.23.16 | ||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
UNLIGANDED SIV PROTEASE STRUCTURE IN AN "OPEN" CONFORMATION
Overview
Rigid body rotation of five domains and movements within their interfacial joints provide a rational context for understanding why HIV protease mutations that arise in drug resistant strains are often spatially removed from the drug or substrate binding sites. Domain motions associated with substrate binding in the retroviral HIV-1 and SIV proteases are identified and characterized. These motions are in addition to closure of the flaps and result from rotations of approximately 6-7 degrees at primarily hydrophobic interfaces. A crystal structure of unliganded SIV protease (incorporating the point mutation Ser 4 His to stabilize the protease against autolysis) was determined to 2.0 A resolution in a new space group, P3221. The structure is in the most "open" conformation of any retroviral protease so far examined, with six residues of the flaps disordered. Comparison of this and unliganded HIV structures, with their respective liganded structures by difference distance matrixes identifies five domains of the protease dimer that move as rigid bodies against one another: one terminal domain encompassing the N- and C-terminal beta sheet of the dimer, two core domains containing the catalytic aspartic acids, and two flap domains. The two core domains rotate toward each other on substrate binding, reshaping the binding pocket. We therefore show that, for enzymes, mutations at interdomain interfaces that favor the unliganded form of the target active site will increase the off-rate of the inhibitor, allowing the substrate greater access for catalysis. This offers a mechanism of resistance to competitive inhibitors, especially when the forward enzymatic reaction rate exceeds the rate of substrate dissociation.
About this Structure
1AZ5 is a Single protein structure of sequence from Simian immunodeficiency virus. Full crystallographic information is available from OCA.
Reference
Domain flexibility in retroviral proteases: structural implications for drug resistant mutations., Rose RB, Craik CS, Stroud RM, Biochemistry. 1998 Feb 24;37(8):2607-21. PMID:9485411
Page seeded by OCA on Thu Mar 20 10:04:11 2008
